Alzheimer’s disease molecular subtypes in a clinical trial cohort
The replication of the five AD molecular subtypes in an independent clinical trial cohort further supports the robustness of these subtypes and paves the way for personalized medicine and novel combination therapy approaches in AD. Reference 1. Tijms, B. M. et al. Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. Nat. Aging 33-47 (2024) doi:10.1038/s43587-023-00550-7.
Authors
- Olav Mjaavatten
- Frode S. Berven (ORCID: https://orcid.org/0009-0001-2726-1812)
- Satya Saxena
- Pallavi Sachdev
- Charlotte E. Teunissen
- Pieter Jelle Visser
- Betty M. Tijms
Institutions
- Eisai (United States) (US)
- Amsterdam University Medical Centers (NL)
- University of Bergen (NO)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_105257
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00